Mycobacteriophages as versatile tools for genetic manipulation of mycobacteria and development of simple methods for diagnosis of mycobacterial diseases

Revista Argentina de Microbiologia

Volumn 41, Issue 1, 2009, Pages 45-55

  Stella, E J ^a   De La Iglesia, A I ^a   Morbidoni, H R ^a,b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Diagnostic tools; Mycobacterial genetics; Mycobacteriophages; Tuberculosis

Indexed keywords

ANTIBIOTIC RESISTANCE; DIAGNOSTIC PROCEDURE; GENETIC MANIPULATION; HUMAN; MYCOBACTERIOPHAGE; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW;

BACTERIOPHAGE TYPING; BODY FLUIDS; HUMANS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIRION;

EID: 65249107211     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Albay A, Kisa O, Baylan O, Doganci L. The evaluation of FASTPlaqueTB test for the rapid diagnosis of tuberculosis. Diagn Microbiol Infect Dis 2003; 46: 211-5.
2. Albert H, Muzaffar R, Mole RJ, Trollip AP. Use of the FASTPlaque test for TB diagnosis in low-income countries. Int J Tuberc Lung Dis 2002; 6: 1130-1.
3. Albert H, Trollip A, Seaman T, Mole RJ. Simple, phagebased (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis 2004; 8: 1114-9.
4. Albert H, Trollip AP, Seaman T, Abrahams C, Mole RJ, Jordaan A, et al. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape. S Afr Med J 2007; 97: 858-63.
5. Alcaide F, Gali N, Dominguez J, Berlanga P, Blanco S, Orus P, et al. Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis. J Clin Microbiol 2003; 41: 2867-71.
6. Banaiee N, Bobadilla-del-Valle M, Bardarov S Jr, Riska PF, Small PM, Ponce-de-Leon A, et al. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol 2001; 39: 3883-8.
7. Banaiee N, Bobadilla-del-Valle M, Riska PF, Bardarov S Jr, Small PM, Ponce-de-Leon A, et al. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol 2003; 52: 557-61.
8. Banaiee N, January V, Barthus C, Lambrick M, Roditi D, Behr MA, et al. Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa. Tuberculosis (Edinb) 2008; 88: 64-8.
9. Banks DJ, Beres SB, Musser JM. The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol 2002; 10: 515-21.
10. Bardarov S Jr, Dou H, Eisenach K, Banaiee N, Ya S, Chan J, et al. Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system. Diagn Microbiol Infect Dis 2003; 45: 53-61.
11. Bardarov S, Bardarov S Jr, Pavelka JM Jr, Sambandamurthy V, Larsen M, Tufariello J, et al. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 2002; 148: 3007-17.
12. Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam RA, et al. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1997; 94: 10961-6.
13. Bates JH, Stead WW, Rado TA. Phage type of tubercle bacilli isolated from patients with two or more sites of organ involvement. Am Rev Respir Dis 1976; 114: 353-8.
14. Behr MA, Mostowy S. Molecular tools for typing and branding the tubercle bacillus. Curr Mol Med 2007; 7: 309-17.
15. Bonington A, Strang JI, Klapper PE, Hood SV, Parish A, Swift PJ, et al. TB PCR in the early diagnosis of tuberculous meningitis: evaluation of the Roche semi-automated COBAS Amplicor MTB test with reference to the manual Amplicor MTB PCR test. Tuber Lung Dis 2000; 80: 191-6.
16. Brussow H. Phages of dairy bacteria. Annu Rev Microbiol 2001; 55: 283-303.
17. Brussow H, Hendrix RW. Phage genomics: small is beautiful. Cell 2002; 108: 13-6.
18. Butt T, Ahmad RN, Kazmi SY, Mahmood A. Rapid diagnosis of pulmonary tuberculosis by mycobacteriophage assay. Int J Tuberc Lung Dis 2004; 8: 899-902.
19. Chauca JA, Palomino JC, Guerra H. Evaluation of rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis by a mycobacteriophage D29-based assay. J Med Microbiol 2007; 56: 360-4.
20. Cheetham BF, Katz ME. A role for bacteriophages in the evolution and transfer of bacterial virulence determinants. Mol Microbiol 1995; 18: 201-8.
21. Chin DP, Yajko DM, Hadley WK, Sanders CA, Nassos PS, Madej JJ, et al. Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med 1995; 151: 1872-7.
22. Christensen AC. Bacteriophage lambda-based expression vectors. Mol Biotechnol 2001; 17: 219-24.
23. Crawford JT, Bates JH. Phage typing of the Mycobacterium avium-intracellulare-scrofulaceum complex. A study of strains of diverse geographic and host origin. Am Rev Respir Dis 1985; 132: 386-9.
24. da Silva PA, Boffo MM de MI, Silva AB, Palomino JC, Martin A, et al. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2006; 12: 293-6.
25. David HL, Clavel S, Clement F, Moniz-Pereira J. Effects of antituberculosis and antileprosy drugs on mycobacteriophage D29 growth. Antimicrob Agents Chemother 1980; 18: 357-9.
26. David HL, Seres-Clavel S, Clement F, Rastogi N. Further observations on the mycobacteriophage D29-mycobacterial interactions. Acta Leprol 1984; 2: 359-67.
27. Davies JR, Carlstedt I. Isolation of large gel-forming mucins. Methods Mol Biol 2000; 125: 3-13.
28. de la Iglesia AI, Stella EJ, Morbidoni HR. Comparison of the performances of two in-house rapid methods for antitubercular drug susceptibility testing. Antimicrob Agents Chemother 2009; 53: 808-10.
29. DeBarber AE, Mdluli K, Bosman M, Bekker LG, Barry CE, III. Ethionamide activation and sensitivity in multidrug resistant Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2000; 97: 9677-82.
30. Del Portillo P, Thomas MC, Martinez E, Maranon C, Valladares B, Patarroyo ME, et al. Multiprimer PCR system for differential identification of mycobacteria in clinical samples. J Clin Microbiol 1996; 34: 324-8.
31. Dover LG, Alahari A, Gratraud P, Gomes JM, Bhowruth V, Reynolds RC, et al. EthA, a common activator of thio- carbamide-containing drugs acting on different mycobacterial targets. Antimicrob Agents Chemother 2007; 51: 1055-63.
32. Dye C, Maher D, Weil D, Espinal M, Raviglione M. Targets for global tuberculosis control. Int J Tuberc Lung Dis 2006; 10: 460-2.
33. Eltringham IJ, Wilson SM, Drobniewski FA. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 3528-32.
34. Escribano I, Rodriguez JC, Llorca B, Garcia-Pachon E, Ruiz M, Royo G. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroqui- nolones and linezolid. Chemotherapy 2007; 53: 397-401.
35. Espinal M, Raviglione MC. From threat to reality: the real face of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2008; 178: 216-7.
36. Ferrari E, Henner DJ, Hoch JA. Isolation of Bacillus subtilis genes from a charon 4A library. J Bacteriol 1981; 146: 430-2.
37. Fullner KJ, Hatfull GF. Mycobacteriophage L5 infection of Mycobacterium bovis BCG: implications for phage genetics in the slow-growing mycobacteria. Mol Microbiol 1997; 26: 755-66.
38. Ghosh P, Kim AI, Hatfull GF. The orientation of mycobacteriophage Bxb1 integration is solely dependent on the central dinucleotide of attP and attB. Mol Cell 2003; 12: 1101-11.
39. Glickman MS, Cox JS, Jacobs WR Jr. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 2000; 5: 717-27.
40. TB. A global emergency, WHO, July 1994. Lepr Rev 1995; 66: 270-1.
41. Grange JM, Zumla A. The global emergency of tuberculosis: what is the cause? J R Soc Health 2002; 122: 78-81.
42. Greco S, Rulli M, Girardi E, Piersimoni C, Saltini C. Diagnostic accuracy of in-house PCR for smear-positive pulmonary tuberculosis: meta-analysis and meta-regression. J Clin Microbiol 2009, Jan 14. (Epublished ahead of print).
43. Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis 1998; 2: 72-89.
44. Hakansson A, Carlstedt I, Davies J, Mossberg AK, Sabharwal H, Svanborg C. Aspects on the interaction of Streptococcus pneumoniae and Haemophilus influenzae with human respiratory tract mucosa. Am J Respir Crit Care Med 1996; 154: S187-91.
45. Hatfull GF. Genetic transformation of mycobacteria. Trends Microbiol 1993; 1: 310-4.
46. Hatfull GF, Cresawn SG, Hendrix RW. Comparative genomics of the mycobacteriophages: insights into bacteriophage evolution. Res Microbiol 2008; 159: 332-9.
47. Hatfull GF, Pedulla ML, Jacobs-Sera D, Cichon PM, Foley A, Ford ME, et al. Exploring the mycobacteriophage metaproteome: phage genomics as an educational platform. PLoS Genet 2006; 2: e92.
48. Hazbon MH, Guarin N, Ferro BE, Rodriguez AL, Labrada LA, Tovar R, et al. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2003; 41: 4865-9.
49. Hellyer TJ, Desjardin LE, Assaf MK, Bates JH, Cave MD, Eisenach KD. Specificity of IS6110-based amplification assays for Mycobacterium tuberculosis complex. J Clin Microbiol 1996; 34: 2843-6.
50. Hendrix RW. Bacteriophages: evolution of the majority. Theor Popul Biol 2002; 61: 471-80.
51. Hendrix RW, Lawrence JG, Hatfull GF, Casjens S. The origins and ongoing evolution of viruses. Trends Microbiol 2000; 8: 504-8.
52. Hohn B. DNA sequences necessary for packaging of bac- teriophage lambda DNA. Proc Natl Acad Sci USA 1983; 80: 7456-60.
53. Hohn B. DNA as substrate for packaging into bacteriophage lambda, in vitro. J Mol Biol 1975; 98: 93-106.
54. Hohn B. In vitro packaging of lambda and cosmid DNA. Methods Enzymol 1979; 68: 299-309.
55. Hohn B, Collins J. A small cosmid for efficient cloning of large DNA fragments. Gene 1980; 11: 291-8.
56. Hohn B, Koukolikova-Nicola Z, Lindenmaier W, Collins J. Cosmids. Biotechnology 1988; 10: 113-27.
57. Hohn B, Murray K. Packaging recombinant DNA molecules into bacteriophage particles in vitro. Proc Natl Acad Sci USA 1977; 74: 3259-63.
58. Hondalus MK, Bardarov S, Russell R, Chan J, Jacobs WR Jr, Bloom BR. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 2000; 68: 2888-98.
59. Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM, et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 2003; 100: 12420-5.
60. Jacobs WR Jr, Barletta RG, Udani R, Chan J, Kalkut G, Sosne G, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993; 260: 819-22.
61. Jimenez-Misas CA, Valdivia Alvarez JA. Distribution of phagetype patterns of Mycobacterium tuberculosis isolated in Cuba (1987-1991). Mem Inst Oswaldo Cruz 1994; 89: 137-8.
62. Kaiser D, Dworkin M. Gene transfer to myxobacterium by Escherichia coli phage P1. Science 1975; 187: 653-4.
63. Kalantri S, Pai M, Pascopella L, Riley L, Reingold A. Bacte- riophage- based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta- analysis. BMC Infect Dis 2005; 5: 59.
64. Kisa O, Albay A, Bedir O, Baylan O, Doganci L. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis 2003; 7: 284-8.
65. Kumaresan J, Heitkamp P, Smith I, Billo N. Global partnership to stop TB: a model of an effective public health partnership. Int J Tuberc Lung Dis 2004; 8: 120-9.
66. Lee MH, Pascopella L, Jacobs WR Jr, Hatfull GF. Site- specific integration of mycobacteriophage L5: integration proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin. Proc Natl Acad Sci USA 1991; 88: 3111-5.
67. Lee S, Kriakov J, Vilcheze C, Dai Z, Hatfull GF, Jacobs WR Jr. Bxz1, a new generalized transducing phage for mycobacteria. FEMS Microbiol Lett 2004; 241: 271-6.
68. Maher D, Dye C, Floyd K, Pantoja A, Lonnroth K, Reid A, et al. Planning to improve global health: the next decade of tuberculosis control. Bull World Health Organ 2007; 85: 341-7.
69. Marei AM, El-Behedy EM, Mohtady HA, Afify AF. Evaluation of a rapid bacteriophage-based method for the detection of Mycobacterium tuberculosis in clinical samples. J Med Microbiol 2003; 52: 331-5.
70. McNerney R, Kambashi BS, Kinkese J, Tembwe R, Godfrey- Faussett P. Development of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis. J Clin Microbiol 2004; 42: 2115-20.
71. McNerney R, Kiepiela P, Bishop KS, Nye PM, Stoker NG. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin. Int J Tuberc Lung Dis 2000; 4: 69-75.
72. McNerney R, Mallard K, Urassa HM, Lemma E, Donoghue HD. Colorimetric phage-based assay for detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1330-2.
73. McNerney R, Wilson SM, Sidhu AM, Harley VS, al-Suwaidi Z, Nye PM, et al. Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis. Res Microbiol 1998; 149: 487-95.
74. Mediavilla J, Jain S, Kriakov J, Ford ME, Duda RL, Jacobs WR Jr, et al. Genome organization and characterization of mycobacteriophage Bxb1. Mol Microbiol 2000; 38: 955-70.
75. Milano A, Pasca MR, Provvedi R, Lucarelli AP, Manina G, Ribeiro AL, et al. Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Tuberculosis (Edinb ) 2009; 89: 84-90.
76. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta- analysis. J Infect 2005; 51: 175-87.
77. Pai M, Kalantri SP. Bacteriophage-based tests for tuberculosis. Indian J Med Microbiol 2005; 23: 149-50.
78. Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002; 46: 2720-2.
79. Park DJ, Drobniewski FA, Meyer A, Wilson SM. Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. J Clin Microbiol 2003; 41: 680-8.
80. Pearson RE, Jurgensen S, Sarkis GJ, Hatfull GF, Jacobs WR Jr. Construction of D29 shuttle phasmids and luciferase reporter phages for detection of mycobacteria. Gene 1996; 183: 129-36.
81. Pedulla ML, Ford ME, Houtz JM, Karthikeyan T, Wadsworth C, Lewis JA et al. Origins of highly mosaic mycobacteriophage genomes. Cell 2003; 113: 171-82.
82. Pham TT, Jacobs-Sera D, Pedulla ML, Hendrix RW, Hatfull GF. Comparative genomic analysis of mycobacteriophage Tweety: evolutionary insights and construction of compatible site-specific integration vectors for mycobacteria. Microbiology 2007; 153: 2711-23.
83. Piuri M, Hatfull GF. A peptidoglycan hydrolase motif within the mycobacteriophage TM4 tape measure protein promotes efficient infection of stationary phase cells. Mol Microbiol 2006; 62: 1569-85.
84. Plikaytis BB, Eisenach KD, Crawford JT, Shinnick TM. Differentiation of Mycobacterium tuberculosis and Mycobacterium bovis BCG by a polymerase chain reaction assay. Mol Cell Probes 1991; 5: 215-9.
85. Querol JM, Farga MA, Granda D, Gimeno C, Garcia-de- Lomas J. The utility of polymerase chain reaction (PCR) in the diagnosis of pulmonary tuberculosis. Chest 1995; 107: 1631-5.
86. Rafi W, Venkataswamy MM, Ravi V, Chandramuki A. Rapid diagnosis of tuberculous meningitis: a comparative evaluation of in-house PCR assays involving three mycobacterial DNA sequences, IS6110, MPB-64 and 65 kDa antigen. J Neurol Sci 2007; 252: 163-8.
87. Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb) 2003; 83: 4-14.
88. Riska PF, Jacobs WR Jr, Bloom BR, McKitrick J, Chan J. Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro- alpha-acetylamino-beta-hydroxy propiophenone. J Clin Microbiol 1997; 35: 3225-31.
89. Riska PF, Su Y, Bardarov S, Freundlich L, Sarkis G, Hatfull G, et al. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol 1999; 37: 1144-9.
90. Rusch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Myco- bacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 2006; 44: 688-92.
91. Sarkis GJ, Jacobs WR Jr, Hatfull GF. L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria. Mol Microbiol 1995; 15: 1055-67.
92. Sassetti CM, Boyd DH, Rubin EJ. Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci USA 2001; 98: 12712-7.
93. Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003; 48: 77-84.
94. Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 2003; 100: 12989-94.
95. Simboli N, Takiff H, McNerney R, Lopez B, Martin A, Palomino JC, et al. In-house phage amplification assay is a sound alternative for detecting rifampin-resistant Mycobacterium tuberculosis in low-resource settings. Antimicrob Agents Chemother 2005; 49: 425-7.
96. Singh S, Saluja TP, Kaur M, Khilnani GC. Comparative evaluation of FASTPlaque assay with PCR and other conventional in vitro diagnostic methods for the early detection of pulmonary tuberculosis. J Clin Lab Anal 2008; 22: 367-74.
97. Snapper SB, Melton RE, Mustafa S, Kieser T, Jacobs WR Jr. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 1990; 4: 1911-9.
98. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, et al. New use of BCG for recombinant vaccines. Nature 1991 6; 351: 456-60.
99. Takano T, Ikeda S. Phage P1 carrying kanamycin resistance gene of R factor. Virology 1976; 70: 198-200.
100. Takiff H, Heifets L. In search of rapid diagnosis and drug- resistance detection tools: is the FASTPlaqueTB test the answer? Int J Tuberc Lung Dis 2002; 6: 560-1.
101. Thierauf A, Perez G, Maloy AS. Generalized transduction. Methods Mol Biol 2009; 501: 267-86.
102. Thomsen VO, Kok-Jensen A, Buser M, Philippi-Schulz S, Burkardt HJ. Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied? J Clin Microbiol 1999; 37: 3601-7.
103. Thornton DJ, Davies JR, Kraayenbrink M, Richardson PS, Sheehan JK, Carlstedt I. Mucus glycoproteins from "normal" human tracheobronchial secretion. Biochem J 1990; 265: 179-86.
104. van Kessel JC, Hatfull GF. Recombineering in Mycobacterium tuberculosis. Nat Methods 2007; 4: 147-52.
105. van Kessel JC, Hatfull GF. Efficient point mutagenesis in mycobacteria using single-stranded DNA recombineering: characterization of antimycobacterial drug targets. Mol Microbiol 2008; 67: 1094-107.
106. van Kessel JC, Hatfull GF. Mycobacterial recombineering. Methods Mol Biol 2008; 435: 203-15.
107. van Kessel JC, Marinelli LJ, Hatfull GF. Recombineering mycobacteria and their phages. Nat Rev Microbiol 2008; 6: 851-7.
108. Vilcheze C, Av-Gay Y, Attarian R, Liu Z, Hazbon MH, Colangeli R, et al. Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol Microbiol 2008; 69: 1316-29.
109. Vilcheze C, Wang F, Arai M, Hazbon MH, Colangeli R, Kremer L, et al. Transfer of a point mutation in Myco- bacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 2006; 12: 1027-9.
110. Wang F, Langley R, Gulten G, Dover LG, Besra GS, Jacobs WR Jr, et al. Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med 2007; 204: 73-8.
111. Williams BG, Blattner FR. Construction and characterization of the hybrid bacteriophage lambda Charon vectors for DNA cloning. J Virol 1979 ; 29: 555-75.
112. Wilson SM, al-Suwaidi Z, McNerney R, Porter J, Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med 1997; 3: 465-8.
113. Yzquierdo SL, Lemus D, Echemendia M, Montoro E, McNerney R, Martin A, et al. Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis. Ann Clin Microbiol Antimicrob 2006; 5: 11.
114. Zimhony O, Cox JS, Welch JT, Vilcheze C, Jacobs WR Jr. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis. Nat Med 2000; 6: 1043-7.